Clinical Trials for NAFLD

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT ID: NCT06465186

This clinical trial is studying a new medicine called efinopegdutide to see if it can help people with a liver disease known as metabolic dysfunction-associated steatohepatitis (MASH), which is cau...

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

NCT ID: NCT07051863

This clinical trial is focused on studying people with a condition called nonalcoholic fatty liver disease (NAFLD) and related liver problems, including NASH and MAFLD. The main goal is to gather d...

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NCT ID: NCT05424003

This clinical trial is studying whether a medication called semaglutide can help prevent weight gain and the development of Non-Alcoholic Fatty Liver Disease (NAFLD) in people who have recently und...

Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.

NCT ID: NCT06705868

This clinical trial is designed to investigate how a specific eating pattern called time-restricted eating (TRE) can help people with metabolic dysfunction-associated steatotic liver disease (MASLD...

Digoxin In NASH (CODIN)

NCT ID: NCT06588699

The clinical trial titled "Digoxin In NASH (CODIN)" is studying the use of digoxin, a medication typically used for heart problems, to see if it can help patients with nonalcoholic steatohepatitis ...

Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

NCT ID: NCT04795219

This clinical trial is called the "Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV." It aims to understand how common a liver condition called nonalcoholic fatty liver dis...

The Effects of Glucagon on Hepatic Metabolism

NCT ID: NCT05500586

This clinical trial is studying how glucagon, a hormone that helps control blood sugar levels, affects the way the liver processes certain nutrients in people with obesity, type 2 diabetes, and non...

GLP-1 RA on Liver OMICS in MASLD

NCT ID: NCT06982378

This clinical trial is looking at how a medication called GLP-1 receptor agonist (GLP-1 RA) can help improve liver health in people who have type 2 diabetes, obesity, and a liver condition known as...

Reversal of Lipid-Induced Insulin Resistance

NCT ID: NCT02193295

This clinical trial is exploring whether losing weight can help improve insulin sensitivity in individuals who are insulin resistant and have a family history of type 2 diabetes. Insulin resistance...

The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.

NCT ID: NCT06334666

Hepatic Elastography-Enhanced Lifestyle Modification in MASLD

NCT ID: NCT06826807

Bicalutamide Therapy in Young Women With NAFLD and PCOS

NCT ID: NCT05979389

This clinical trial is investigating how a treatment called bicalutamide might help young women who have nonalcoholic steatohepatitis (NASH) and polycystic ovary syndrome (PCOS). NASH is a conditio...

Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)

NCT ID: NCT06856252

This clinical trial is studying a condition called non-alcoholic steatohepatitis (NASH), which is a type of liver disease related to fat buildup in the liver. Researchers are creating special 3D mo...

Target of Suv420h1/2 in Hepatocytes

NCT ID: NCT06332677

This clinical trial is investigating a potential new approach to treat nonalcoholic fatty liver disease (NAFLD), which is a common liver condition that can lead to serious problems like cirrhosis a...

Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD

NCT ID: NCT06186869

This clinical trial is looking at how two different exercise programs, combined with the Mediterranean diet, compare to just following the diet alone in helping people with obesity and a liver cond...

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

NCT ID: NCT05930093

This clinical trial is studying a new treatment called LivPhcD™ capsules for people with non-alcoholic fatty liver disease (NAFLD). NAFLD occurs when too much fat builds up in the liver without any...

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

NCT ID: NCT04186260

This clinical trial is looking at a specific way to help Mexican-American men who have a condition called non-alcoholic fatty liver disease (NAFLD). The study will focus on men who carry a certain ...

Effect of CoQ10 on the Outcome of MAFLD Patients

NCT ID: NCT05984745

This clinical trial is studying the effects of a supplement called coenzyme Q10 (CoQ10) on patients with a condition called Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). MAFLD is a ...

Androgens and NAFLD Longitudinal Cohort Study

NCT ID: NCT06124261

The Androgens and NAFLD Longitudinal Cohort Study is researching how androgens, which are hormones in the body, may influence a liver condition called nonalcoholic fatty liver disease (NAFLD) in yo...

Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease

NCT ID: NCT06879236

This clinical trial is exploring a new way to help people with a liver condition called Metabolic dysfunction-associated steatotic liver disease (MASLD), which can lead to serious health issues lik...